Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron-a
schering-plough a division of schering-plough animal health limited - interferon alfa-2b 5 miu/ml; - solution for injection - 5 miu/ml - active: interferon alfa-2b 5 miu/ml excipient: albumin dibasic sodium phosphate glycine methyl hydroxybenzoate monobasic sodium phosphate monohydrate propyl hydroxybenzoate water for injection
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron-a
merck sharp & dohme (new zealand) limited - interferon alfa-2b 6 miu/ml; - solution for injection - 6 miu/ml - active: interferon alfa-2b 6 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a redipen interferon alfa-2b (rbe) 60 million iu/1.2ml injection cartridge
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a redipen interferon alfa-2b (rbe) 30 million iu/1.2ml injection cartridge
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a redipen interferon alfa-2b (rbe) 18 million iu/1.2ml injection cartridge
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a interferon alfa-2b ( hsa-free ) 10 million iu/1ml injection vial
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a interferon alfa-2b (hsa-free) 25 million iu/2.5ml injection
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a interferon alfa-2b (hsa-free) 18 million iu/3ml injection
merck sharp & dohme (australia) pty ltd - interferon alfa-2b -
États-Unis -
anglais -
NLM (National Library of Medicine)
intron a- interferon alfa-2b kit intron a- interferon alfa-2b injection, solution
merck sharp & dohme llc - interferon alfa-2b (unii: 43k1w2t1m6) (interferon alfa-2b - unii:43k1w2t1m6) - interferon alfa-2b 38 ug in 1 ml - intron® a is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. intron a is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease but at high risk for systemic recurrence, within 56 days of surgery. intron a is indicated for the initial treatment of clinically aggressive (see clinical pharmacology ) follicular non-hodgkin's lymphoma in conjunction with anthracycline-containing combination chemotherapy in patients 18 years of age or older. efficacy of intron a therapy in patients with low-grade, low-tumor burden follicular non-hodgkin's lymphoma has not been demonstrated. intron a is indicated for intralesional treatment of selected patients 18 years of age or older with condylomata acuminata involving external surfaces of the genital and perianal areas (see dosage and administration ). the use of this product in adolescents has not been studied. intron a is indicated for the treatment of select
